Product Name |
Product Number |
Supplier |
Size |
|
| Rat histamine receptor 3 (H3R) control (blocking) peptide #1 |
H3R31-P |
Alpha Diagnostic |
100 ug |
|
| Human histamine receptor 3 (H3R) control (blocking) peptide #2 |
H3R32-P |
Alpha Diagnostic |
100 ug |
|
| Human histamine receptor 4 (H4R) control (blocking) peptide #1 |
H4R41-P |
Alpha Diagnostic |
100 ug |
|
| Hemeagglutinin fusion epitope (HA-tag) Control/blocking peptide#1 |
HA11-P |
Alpha Diagnostic |
100 ug |
|
| Hemeagglutinin fusion epitope (HA-tag) Control/blocking peptide#1 |
HA12-P |
Alpha Diagnostic |
100 ug |
|
| Hemeagglutinin fusion epitope (HA-tag) Control/blocking peptide#1 |
HA12-P-1000 |
Alpha Diagnostic |
1 mg |
|
| Human beta-Defensin 1 (BD-1/hBD-1) control/blocking peptide #1 |
HBD12-P |
Alpha Diagnostic |
100 ug |
|
| Human beta-Defensin 1 (BD-1/hBD-1) full length (36 aa, oxidized) synthetic peptide; note: replaces HBD13-P |
HBD16-P |
Alpha Diagnostic |
100 ug |
|
| Human beta-Defensin 2 (BD-2/hBD-2)control/blocking peptide #1 |
HBD21-P |
Alpha Diagnostic |
100 ug |
|
| Human beta-Defensin 2 (BD-2/hBD-2) full length synthetic peptide (41 aa, linear, no-disulfides); note: replaces HBD22-P. |
HBD24-P |
Alpha Diagnostic |
100 ug |
|
| Human beta-Defensin 3 (BD-3) control/blocking peptide #1 |
HBD31-P |
Alpha Diagnostic |
100 ug |
|
| Rabbit Anti-Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide IgG, aff pure |
HBVS12-A |
Alpha Diagnostic |
100 ul |
|
| Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide control/blocking peptide |
HBVS12-P |
Alpha Diagnostic |
100 ug |
|
| Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide-Biotin (2-48-aa, >90%, ~5.5 kda) |
HBVS16-B-100 |
Alpha Diagnostic |
100 ug |
|
| Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide-FITC (2-48-aa, >95%, ~5.6 kda) |
HBVS16-F-100 |
Alpha Diagnostic |
100 ug |
|
| Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide (2-48-aa, >95%, ~5.2 kda), unlabeled |
HBVS16-U-100 |
Alpha Diagnostic |
100 ug |
|
| Myristoylated-Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide-Biotin (2-48-aa, >90%, ~5.7 kda) |
HBVS17-B-100 |
Alpha Diagnostic |
100 ug |
|
| Myristoylated-Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide-FITC (2-48-aa, >90%, ~5.8 kda) |
HBVS17-F-100 |
Alpha Diagnostic |
100 ug |
|
| Myristoylated-Hepatitis B Surface Antigen (HBsAg) pre-S1 peptide (2-48-aa, >98%, ~5.4 kda) |
HBVS17-U-100 |
Alpha Diagnostic |
100 ug |
|
| Hepatitis B Surface Antigen (HBsAg) pre-S2 (55-aa) control/blocking peptide |
HBVS23-P |
Alpha Diagnostic |
100 ug |
|
| Human Hyperpolarization-activated Cyclic Nucleotide-gated channel 1 (HCN1) Control/blocking peptide |
HCN11-P |
Alpha Diagnostic |
100 ug |
|
| Human Hyperpolarization-activated Cyclic Nucleotide-gated channel 2 (HCN2) Control/blocking peptide |
HCN21-P |
Alpha Diagnostic |
100 ug |
|
| Mouse Hyperpolarization-activated Cyclic Nucleotide-gated channel 3 (HCN3) Control/blocking peptide |
HCN31-P |
Alpha Diagnostic |
100 ug |
|
| Rat Hyperpolarization-activated Cyclic Nucleotide-gated channel 4 (HCN4) Control/blocking peptide |
HCN41-P |
Alpha Diagnostic |
100 ug |
|
| Human Hyperpolarization-activated Cyclic Nucleotide-gated channel 1 (HCN1-pore) Control/blocking peptide |
HCNP15-P |
Alpha Diagnostic |
100 ug |
|
| Human Alpha Defensin 1-3 (NP1-3/hNP1-3)control/blocking peptide #1 |
HDEFA11-P |
Alpha Diagnostic |
100 ug |
|
| Human Alpha Defensin 4 (NP-4) control/blocking peptide #1 |
HDEFA41-P |
Alpha Diagnostic |
100 ug |
|
| Human Alpha Defensin 5 (NP-5),control/blocking peptide #1 |
HDEFA51-P |
Alpha Diagnostic |
100 ug |
|
| Human Alpha Defensin 6 (NP-6) control/blocking peptide #1 |
HDEFA61-P |
Alpha Diagnostic |
100 ug |
|
| Human HE2 Control/blocking peptide #1 |
HE21-P |
Alpha Diagnostic |
100 ug |
|
Products
